3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
6
Lung Neoplasms
5
Colorectal Neoplasms
5
Prostatic Neoplasms
3
Motor Activity
3
Hodgkin Disease
2
Hematopoietic and Lymphoid System Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Stress Disorders, Post-Traumatic
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pathologically Proven Gastrointestinal Malignancy
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Insulin Resistance
1
Inflammatory Breast Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Head and Neck Neoplasms
1
Fatigue
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Depression
1
Interventions
Metformin
12
Exercise
6
Inositol
4
High-Intensity Interval Training
3
Ethinyl Estradiol
3
Water
2
Preoperative Exercise
2
Insulin
2
Cyproterone Acetate
2
Acupuncture Therapy
2
ziprasidone
1
exendin (9-39)
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
adrenosterone
1
Telemedicine
1
Tablets
1
Sugars
1
Standard of Care
1
Resistance Training
1
Pioglitazone
1
Phlebotomy
1
Olanzapine
1
Magnesium Oxide
1
Magnesium
1
Ketones
1
Human Growth Hormone
1
Health Planning Guidelines
1
Growth Hormone
1
Folic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Insulin Resistance
×
Exercise Test
×
Clear all
NCT05215223
2023-10-17
WBV
Cairo University
Phase NA
Completed
46 enrolled